Producing organism:

Streptomyces nashvillensis MD743-GF4



Clinical use:


Class no:

8 Reference(s)

Search PubMed »

Please scroll horizontally.

Title Author Journal Year Volume Page
D-β-Lysylmethanediamine, a new biogenetic amine produced by a Streptomyces. Y. Ikeda; S. Kondo; D. Ikeda; K. Yokose; H. Furutani; T. Ikeda; M. Hamada; M. Ishizuka; T. Takeuchi; H. Umezawa J. Antibiotics 1986 39 476-478
Total syntheses of bellenamine and its isomers. Y. Ikeda; D. Ikeda; S. Kondo J. Antibiotics 1992 45 1677-1680
Production of bellenamine and new metabolites in a synthetic medium. Y. Ikeda; S. Gomi; M. Hamada; S. Kondo; T. Takeuchi J. Antibiotics 1992 45 1763-1766
Biosynthesis of bellenamine by Streptomyces nashvillensis using stable isotope labeled compounds. Y. Ikeda; H. Naganawa; S. Kondo; T. Takeuchi J. Antibiotics 1992 45 1919-1924
Preparation of 13C and 15N labeled bellenamine and its degradation products. Y. Ikeda; H. Naganawa; S. Kondo; T. Takeuchi J. Antibiotics 1992 45 1925-1929
Tetrahydro-4(1H)-pyrimidinone ring formation of bellenamine, a biogenic amine, with carbonyl compounds. Y. Ikeda; S. Gomi; H. Naganawa; D. Ikeda; S. Kondo Bull. Chem. Soc. Jpn. 1994 67 1904-1911
New bellenamine homologs inhibiting human immunodeficiency virus type 1 infectivity. S. Kondo; Y. Ikeda; T. Takeuchi; R. Shinei; S. Gomi; S. Shibahara; Y. Haraguchi; R. Ikeda; H. Hoshino J. Antibiotics 1996 49 113-114
Inhibition of human immunodeficiency virus type 1 infectivity by a new amine bellenamine. R. Ikeda; Y. Haraguchi; Y. Ikeda; S. Kondo; T. Takeuchi; H. Hoshino Antiviral Research 1996 29 163-173